Summary: GLP-1 medications do not directly affect periods, but the significant weight loss they cause can indirectly influence menstrual regularity through hormonal and metabolic changes
Because Retatrutides nausea rate (28%) is substantially lower than Semaglutides (44%), some people who found Semaglutide intolerable may handle Retatrutide significantly better
Additionally, the limited supply of many of these products has increasingly shifted toward use in obesity treatment, driven by profit motives, leaving many type 2 diabetes patients unable to access medications they rely upon
This affects sourcing, cost, and quality assurance considerations
How often should kidney function be monitored if I take both semaglutide and blood thinners
Follow her @ByJessBartlett.